Literature DB >> 7511111

Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase.

S Reddy1, B B Aggarwal.   

Abstract

Recently, we reported that curcumin (diferuloylmethane) inhibits the growth of several different kinds of tumor cells. In order to investigate the mechanism of this inhibition, we examined the effects of curcumin on different protein kinases: highly purified protein kinase A (PkA), protein kinase C (PkC), protamine kinase (cPK), phosphorylase kinase (PhK), autophosphorylation-activated protein kinase (AK) and pp60c-src tyrosine kinase. While all kinases tested were inhibited by curcumin, only PhK was completely inhibited at relatively lower concentrations. At around 0.1 mM curcumin, PhK, pp60c-src, PkC, PkA, AK, and cPK were inhibited by 98%, 40%, 15%, 10%, 1%, and 0.5%, respectively. Lineweaver-Burk plot analysis indicated that curcumin is a non-competitive inhibitor of PhK with a Ki of 0.075 mM. Overall, our results indicate that curcumin is a potent and selective inhibitor of phosphorylase kinase, a key regulatory enzyme involved in the metabolism of glycogen. This has important implications for the anti-proliferative effects of curcumin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511111     DOI: 10.1016/0014-5793(94)80232-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  51 in total

Review 1.  Novel agents for chemoprevention, screening methods, and sampling issues.

Authors:  Mary Jo Fackler; Ella Evron; Seema A Khan; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

2.  Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication.

Authors:  Xiaoning Si; Yahong Wang; Jerry Wong; Jingchun Zhang; Bruce M McManus; Honglin Luo
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 3.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

4.  Effects of curcumin on the gene expression profile of L-02 cells.

Authors:  Mingjie Zhou; Chunlei Fan; Nan Tian
Journal:  Biomed Rep       Date:  2015-05-04

5.  Inhibition of lipoxygenase 1 by phosphatidylcholine micelles-bound curcumin.

Authors:  G Began; E Sudharshan; A G Appu Rao
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

6.  Curcumin Inhibits Protein Kinase Cα Activity by Binding to Its C1 Domain.

Authors:  Satyabrata Pany; Youngki You; Joydip Das
Journal:  Biochemistry       Date:  2016-11-02       Impact factor: 3.162

Review 7.  Therapeutic roles of curcumin: lessons learned from clinical trials.

Authors:  Subash C Gupta; Sridevi Patchva; Bharat B Aggarwal
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

8.  [Aspects of traditional Indian medicine (Ayurveda) in urology].

Authors:  J Mani; S Kumar; G J Dobos; A Haferkamp
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

9.  Antihyperlipidemic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione, a curcumin analog, on nicotine and streptozotocin treated rats.

Authors:  Bandugula Venkata Reddy; J Sivagama Sundari; Elumalai Balamurugan; Venugopal Padmanabhan Menon
Journal:  Mol Cell Biochem       Date:  2009-09-30       Impact factor: 3.396

Review 10.  Regulation of Ca2+ signaling with particular focus on mast cells.

Authors:  Hong-Tao Ma; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.